Invalidity dossier

US 11872029

Devices and methods for sleep disorder diagnosis and treatment

Current assignee: Resmed Corp.

Added 6/30/2026, 12:02:07 AM

IndustryMedical (M)

Active provider: Google · gemini-2.5-flash

Auto-generating section 1 of 2: Extensions

Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

Here's a concise summary of US patent 11872029:

US Patent 11872029: Devices and methods for sleep disorder diagnosis and treatment

  • Title: Devices and methods for sleep disorder diagnosis and treatment
  • Assignee: Cleveland Medical Devices Inc
  • Inventors: Hani Kayyali, Robert Schmidt, Mohammad Modarres-Zadeh, Brian Kolkowski
  • Filing Date: February 3, 2023
  • Issue Date: January 16, 2024
  • Abstract: The patent describes an integrated device and method for diagnosing and treating sleep disorders, specifically focusing on apnea.

Plain-Language Overview of Independent Claims:

  • Independent Claim 1 (System): This claim details a sleep disorder treatment system that includes two main parts: a diagnostic device and a treatment device. The diagnostic device is designed to collect physiological signals from a person, analyze these signals to determine how severe a sleep disorder or its symptoms are, and then produce an output indicating this severity. The treatment device is configured to deliver a physical or chemical treatment for the sleep disorder or its symptoms and is capable of automatically adjusting that treatment based on the output from the diagnostic device.

  • Independent Claim 11 (Method): This claim outlines a method for treating a subject's sleep disorder. The method involves several steps: first, acquiring physiological signals from the subject using a diagnostic device; second, analyzing these signals with the diagnostic device to assess the severity of the sleep disorder or its symptoms; third, generating an output that represents this severity; fourth, transmitting this output from the diagnostic device to a separate treatment device; fifth, providing a physical or chemical treatment to the subject using the treatment device; and finally, automatically adjusting the physical or chemical treatment based on the received output.

CAFC 2026 Dockets:
A search for CAFC 2026 dockets for US patent 11872029 did not yield any specific results. However, the patent's Google Patents page indicates a PTAB case, IPR2025-00247, which is currently pending and instituted. This is a Patent Trial and Appeal Board (PTAB) proceeding, not a case in the U.S. Court of Appeals for the Federal Circuit (CAFC).

Generated 6/30/2026, 12:45:42 AM